Longitudinal trends in cardiovascular mortality and blood pressure levels, prevalence, awareness, treatment, and control of hypertension in the Czech population from 1985 to 2007/2008

Journal of Hypertension

Volumn 28, Issue 11, 2010, Pages 2196-2203

  Cífková, Renata ^a   Škodová, Zdenka ^a   Bruthans, Jan ^a   Holub, Jiří ^b   Adámková, Věra ^a   Jozífová, Marie ^a   Galovcová, Markéta ^a   Wohlfahrt, Peter ^a   Krajčoviechová, Alena ^a   Petržílková, Zdena ^a   Lánská, Věra ^a  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^b Institute of Health Information and Statistics of the Czech Republic   (Czech Republic)

Author keywords

antihypertensive medication; cross sectional surveys; Czech post MoNItoring of CArdiovascular Disease study; ischemic heart disease mortality; population random sample; stroke mortality; WHO MoNItoring of CArdiovascular Disease Project

Indexed keywords

ADULT; AGED; ARTICLE; AWARENESS; BLOOD PRESSURE REGULATION; BODY HEIGHT; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CLINICAL EXAMINATION; CZECH REPUBLIC; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION SYSTEM; MORTALITY; PREVALENCE; PRIORITY JOURNAL; PULSE PRESSURE; SCREENING TEST; STROKE; SYSTOLIC BLOOD PRESSURE;

EID: 77958512838     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32833d4451     Document Type: Article

References (28)

1. European cardiovascular disease statistics 2008. 3rd ed. Brussels: European Heart Network 2008.
2. Sans S, Kesteloot H, Kromhout D. The burden of cardiovascular diseases mortality in Europe. Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity Statistics in Europe. Eur Heart J 1997; 18:1231-1248.
3. Müller-Nordhorn J, Rossnagel K, Mey W, Willich SN. Regional variation and time trends in mortality from ischaemic heart disease: East and West Germany 10 years after reunification. J Epidemiol Commun Health 2004; 58:481-485.
4. Zatonski WA, McMichael AJ, Powles JW. Ecological study of reasons for sharp decline in mortality from ischaemic heart disease in Poland since 1991. BMJ 1998; 316:1047-1051.
5. Müller-Nordhorn J, Binting S, Roll S, Willich SN. An update on regional variation in cardiovascular mortality within Europe. Eur Heart J 2008; 29:1316-1326.
6. Kesteloot H, Sans S, Kromhout D. Dynamics of cardiovascular and all-cause mortality in Western and Eastern Europe between 1970 and 2000. Eur Heart J 2006; 27:107-113.
7. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al., and INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364:937-952.
8. Lawes CMM, Hoorn SV, Rodgers A, for the International Society of Hypertension. Global burden of blood-pressure-related disease, 2001. Lancet 2008; 371:1513-1518.
9. WHO. International statistical classification of diseases and related health problems. Vol. 1. 10th ed. Geneva: WHO; 1992.
10. Levi F, Lucchini F, Negri E, La Vecchia C. Trends in mortality from cardiovascular and cerebrovascular diseases in Europe and other areas of the world. Heart 2002; 88:119-124.
11. Ascherio A, Hennekens C, Willett WC, Sacks F, Rosner B, Manson JA, et al. Prospective study on nutritional factors, blood pressure, and hypertension among US women. Hypertension 1996; 27:1065-1072.
12. Food consumption data released by the Czech Statistical Office. http:/ www.czso.cz. Table 03.02: Food consumption and nonalcoholic beverages in 1989-2007.
13. Cífková R, Skodová Z, Bruthans J, Adámková V, Jozífová M, Galovcová M, et al. Longitudinal trends in major cardiovascular risk factors in the Czech population between 1985 and 20078/08. Czech MONICA and Czech post-MONICA. Atherosclerosis 2010. DOI: 10.1016/ j.atherosclerosis.2010.04.007.
14. Guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. Bull World Health Organ 1993; 71:503-517.
15. He FJ, MacGregor GA. A comprehensive review on salt and health and current experience of worldwide salt reduction programmes. J Hum Hypertens 2009; 23:363-384.
16. He FJ, Markandu ND, Sagnella GA, MacGregor GA. Effect of salt intake on renal excretion of water in humans. Hypertension 2001; 38:317-320.
17. He FJ, Marrero NM, MacGregor GA. Salt intake is related to soft drink consumption in children and adolescents: a link to obesity? Hypertension 2008; 51:629-634.
18. Cutler JA, Sorlie PD, Wolz M, Thom T, Fields LE, Roccella EJ. Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999-2004. Hypertension 2008; 52:818-827.
19. Erdine S, Aran SN. Current status of hypertension control around the world. Clin Exp Hypertens 2004; 26:731-738.
20. Leenen FH, Dumais J, McInnis NH, Turton P, Stratychuk L, Nemeth K, et al. Results of the Ontario survey on the prevalence and control of hypertension. CMAJ 2008; 178:1441-1449.
21. Soltero I, Cooper R, Liu K, Stamler J, Garside D. Trends in mortality from cerebrovascular disease in the United States, 1960 to 1975. Stroke 1978; 9:549-558.
22. Hunink MG, Goldman L, Tosteson AN, Mittleman MA, Goldman PA, Williams LW, et al. The recent decline in mortality from coronary heart disease, 1980-1990. The effect of secular trends in risk factors and treatment. JAMA 1997; 277:535-542.
23. Redón J, Cea-Calvo L, Lozano JV, Martí-Canales JS, Llisterri JL, Aznar J, Gonzá lez-Esteban J, on behalf of the investigators of the PREV-ICTUS Study. Differences in blood pressure control and stroke mortality across Spain. The Prevención de Riesgo de Ictus (PREV-ICTUS) Study. Hypertension 2007; 49:799-805.
24. Cooper RS. Using public health indicators to measure the success of hypertension control. Hypertension 2007; 49:773-774.
25. Critchley J, Capewell S. Why model coronary heart disease? Eur Heart J 2002; 23:110-116.
26. Capewell S, Beaglehole R, Seddon M, McMurray J. Explaining the decline in coronary heart disease mortality in Auckland, New Zealand between 1982 and 1993. Circulation 2005; 102:1511-1516.
27. Laatikainen T, Critchley J, Vartiainen E, Salomaa V, Ketonen M, Capewell S. Explaining the decline in coronary heart disease mortality in Finland between 1982 and 1997. Am J Epidemiol 2005; 8:764-773.
28. Unal B, Critchley JA, Capewell S. Explaining the decline in coronary heart disease mortality in England and Wales between 1990 and 2005. Circulation 2004; 109:1101-1107.